HIV pre-exposure prophylaxis.
Publication
, Journal Article
Morin, SF; Yamey, G; Rutherford, GW
Published in: BMJ (Clinical research ed.)
August 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
August 2012
Volume
345
Start / End Page
e5412
Related Subject Headings
- United States Food and Drug Administration
- United States
- Organophosphorus Compounds
- Humans
- HIV Infections
- General & Internal Medicine
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Drug Combinations
- Drug Approval
- Deoxycytidine
Citation
APA
Chicago
ICMJE
MLA
NLM
Morin, S. F., Yamey, G., & Rutherford, G. W. (2012). HIV pre-exposure prophylaxis. BMJ (Clinical Research Ed.), 345, e5412. https://doi.org/10.1136/bmj.e5412
Morin, Stephen F., Gavin Yamey, and George W. Rutherford. “HIV pre-exposure prophylaxis.” BMJ (Clinical Research Ed.) 345 (August 2012): e5412. https://doi.org/10.1136/bmj.e5412.
Morin SF, Yamey G, Rutherford GW. HIV pre-exposure prophylaxis. BMJ (Clinical research ed). 2012 Aug;345:e5412.
Morin, Stephen F., et al. “HIV pre-exposure prophylaxis.” BMJ (Clinical Research Ed.), vol. 345, Aug. 2012, p. e5412. Epmc, doi:10.1136/bmj.e5412.
Morin SF, Yamey G, Rutherford GW. HIV pre-exposure prophylaxis. BMJ (Clinical research ed). 2012 Aug;345:e5412.
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
August 2012
Volume
345
Start / End Page
e5412
Related Subject Headings
- United States Food and Drug Administration
- United States
- Organophosphorus Compounds
- Humans
- HIV Infections
- General & Internal Medicine
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Drug Combinations
- Drug Approval
- Deoxycytidine